anmelden
BX Swiss TOP 30 CHF
1.390,10
PKT
-4,24
PKT
-0,30
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 24.04.23 | UBS Hold | Jefferies & Company Inc. | |
| 24.04.23 | UBS Sector Perform | RBC Capital Markets | |
| 24.04.23 | Givaudan Sell | UBS AG | |
| 21.04.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 21.04.23 | Roche Sell | Deutsche Bank AG | |
| 21.04.23 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 19.04.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 19.04.23 | UBS Sector Perform | RBC Capital Markets | |
| 19.04.23 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 18.04.23 | Roche Hold | Jefferies & Company Inc. | |
| 18.04.23 | Novartis Buy | Jefferies & Company Inc. | |
| 18.04.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 18.04.23 | Givaudan Underperform | Bernstein Research | |
| 17.04.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 17.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 17.04.23 | Givaudan Sell | UBS AG | |
| 17.04.23 | Givaudan Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.04.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 14.04.23 | Givaudan Hold | Deutsche Bank AG | |
| 14.04.23 | Givaudan Underperform | Bernstein Research | |
| 13.04.23 | Richemont Buy | UBS AG | |
| 13.04.23 | Swiss Re Equal Weight | Barclays Capital | |
| 13.04.23 | Givaudan Underperform | Bernstein Research | |
| 13.04.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 13.04.23 | Givaudan Sell | UBS AG | |
| 13.04.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 12.04.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 12.04.23 | Givaudan Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.04.23 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 12.04.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 11.04.23 | Novartis Underweight | Barclays Capital | |
| 11.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 11.04.23 | UBS Overweight | JP Morgan Chase & Co. | |
| 06.04.23 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
| 06.04.23 | Zurich Insurance Buy | UBS AG | |
| 06.04.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 05.04.23 | Richemont Buy | UBS AG | |
| 05.04.23 | ABB (Asea Brown Boveri) Buy | Goldman Sachs Group Inc. | |
| 05.04.23 | Richemont Overweight | JP Morgan Chase & Co. | |
| 05.04.23 | Nestlé Market-Perform | Bernstein Research |